Trade associations 'just say no'
This article was originally published in The Tan Sheet
Executive Summary
FDA urged to take action against companies selling "herbal" products and "supplements" as "street drug alternatives" in an April 7 letter from AHPA, CRN, NNFA and UNPA. In the letter, the trade associations praise CDER's "Guidance for Industry: Street Drug Alternatives," published in the April 3 Federal Register, but call for further action, saying "we are concerned that the agency might not act as promptly or forcefully as we believe is appropriate." The groups "strongly urge FDA to use the full enforcement authority" in its power, "including seizure and/or injunction" against such products, many of which contain GHB or ephedra